Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.
Reader sentiment, not investment advice. One vote per visitor; click again to change it.
INCY is priced at $119.39 right now, down 1.62% on the session. That puts its market value at $24.20B, 509th largest among the 800 stocks we cover.
Over a full year the shares have ranged across $82.82 to $132.60, which puts the current price roughly 73% of the way up that band. Holders are ahead 37.7% over twelve months, and up 4.9% across the last three months.
Price is below the 50-day average ($123.63) but above the 200-day ($106.66); RSI is 44, and the last 30 sessions moved at roughly 26% annualized volatility.
For the quarter ended Jun 2026 it reported $1.67B in revenue, up 37.7% from a year earlier, with $585.61M of net profit (a 27.7% margin).
Buyers are paying 15.2 times trailing earnings, 86% below its five-year average of 107.6. The median for its industry group is 33.3.
14 analysts follow the stock and the average call is "buy". The mean target, $140.67, sits 17.8% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 3 factors below, ranked against the 800 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Trading closer to its 52-week high than most peers scores higher.
14 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
INCY is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $140.67, 17.8% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $86.00, so shares trade 38.8% above that estimate. On earnings multiple, it sits in the 7th percentile of its own five-year valuation range (cheaper than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | -4.3% | Bearish |
| Price vs 50-day average | -3.4% | Bearish |
| Price vs 200-day average | +11.9% | Bullish |
| 50-day vs 200-day | 50d above 200d | Bullish |
| RSI (14) | 43.5 | Bearish |
| MACD (12,26,9) | -0.06 | Bearish |
| Bollinger band position | -11% | Neutral |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Oct 1, 2026 11:50 am ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 15.2x earnings, INCY looks cheap against the market, and trades 54% below the 33.3x median among Biotechnology names. The two comparisons do not always agree.
$119.39 is the latest print for INCY, a move of -1.62% against yesterday's close of $121.35. Today's low and high so far: $119.02 and $121.22.
Equity value comes to $24.20B at the current price. By that measure it is number 509 of the 800 names in our coverage.
Buyers pay 15.2 times the last twelve months of profit (EPS $6.41). Averaged over five years the multiple has been 107.6, and today's level ranks in the 7th percentile of its own history.
The year's floor is $82.82 and the ceiling $132.60. Shares are 10.0% away from that ceiling.
Our data shows no dividend paid by Incyte over the trailing twelve months.
Of 14 analysts, 79% say buy, 21% hold and 0% sell. Price targets average $140.67, with the most cautious at $120.00 and the most optimistic at $155.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on INCY.